Artigo Revisado por pares

The likelihood of attaining and maintaining DMARD-free remission for various (rheumatoid) arthritis phenotypes

2021; Oxford University Press; Volume: 61; Issue: 6 Linguagem: Inglês

10.1093/rheumatology/keab631

ISSN

1462-0332

Autores

Nathalie Luurssen‐Masurel, Elise van Mulligen, A. Weel, Johanna Maria Wilhelmina Hazes, Pascal H P de Jong, R C Aartsen, C Alfenaar, Rute Alves, Michael Arendse, M Arnoldus, J Baak-Dijkstra, P Bal-overzier, N Barendregt, S Basoski, David G. Beer, F Berkel, M Bönte, D Born van den, Schaik van, H. Bron, Ned Buijs, Mara Buijs, Danièle Cambier, S Cateten, E Claessen, Alicia Colin, Rebecca L. Dekker, M Dolhain, F Donze, A Fodili, G Gerards, B Goudeketting, H Grillet de, B Haasnoot, K Hamelink, Junyan Han, Y Hazes, L Houdt van, M Hove van, J. Huisman, M Jager de, Ji De, C Jasperse, S Jonkers, C Joziasse, K Kaal-Alfenaar, T Klootwijk, M Krommenhoek, T Krugten van, W Kuijper, H Lam Tse, Cassandra Van, M Legierse, P Lenssinck, Park De, Y Maclean, Dibyendu De, A Matena, L Molenaar, Jan Mous, H. G. T. Nijs, Rory Van, J Quax, A Reijnierse, M Romme, M Rotte de, B Saltzherr, G Schaeybroeck, S Schardijn, Patrick Schrauwen, F Sonnaville de, Lai De, Tamera Sturm, Iryna Sutter, D Tchetverikov, R Tusschenbroek, M.G. Veldman, André N. Vis, Henrietta Dér, M Voorneveld, Markson De, M. Walravens, Andrew W. Walter, N Weel, Ananya De, J Westeinde van het, M Van de Wiele, J. Willemse, Willaert Wouter, Dina Zandbergen, H Zeben van, Zwart,

Tópico(s)

Systemic Lupus Erythematosus Research

Resumo

To compare (sustained) DMARD-free remission rates((S)DFR), defined as respectively ≥6 months and >1 year, after 2 and 5 years between three clinical arthritis phenotypes; undifferentiated arthritis(UA), autoantibody-negative(RA-) and positive rheumatoid arthritis(RA+).

Referência(s)
Altmetric
PlumX